CYSB2100068 | 精蛋白人胰岛素注射液 | Isophane Protamine Human Insulin | Injection | Biological Products | Supplementary Application | 2021-03-09 | 诺和诺德(中国)制药有限公司 | Novo Nordisk (China) Pharmaceuticals Co Ltd | Certificate Issued | 2022-01-14 | view |
CYSB2100067 | 精蛋白人胰岛素注射液 | Isophane Protamine Human Insulin | Injection | Biological Products | Supplementary Application | 2021-03-09 | 诺和诺德(中国)制药有限公司 | Novo Nordisk (China) Pharmaceuticals Co Ltd | Certificate Issued | 2022-01-14 | view |
CYSB2000033 | 重组人胰岛素注射液 | human insulin | Injection | Biological Products | Supplementary Application | 2020-03-14 | 江苏万邦生化医药集团有限责任公司 | Wanbang Biopharmaceuticals | Certificate Issued | 2021-12-15 | view |
CYSB2000247 | 重组人胰岛素注射液 | human insulin | Injection | Biological Products | Supplementary Application | 2020-10-30 | 礼来苏州制药有限公司 | Lilly Suzhou Pharmaceutical Co Ltd | Certificate Issued | 2021-08-06 | view |
JYSZ2100005 | 精蛋白人胰岛素注射液 | Isophane Protamine Human Insulin | Injection | Biological Products | License Renew | 2021-03-11 | 诺和诺德(中国)制药有限公司 | Novo Nordisk (China) Pharmaceuticals Co Ltd | Certificate Issued | 2021-08-04 | view |
CXSS1400015 | 精蛋白重组人胰岛素注射液(预混30R) | | Injection | Biological Products(15) | New Drug Application | 2015-01-19 | 甘李药业股份有限公司 | Gan & Lee Pharmaceuticals | Certificate Issued | 2021-05-31 | view |
JYSB2000168 | 重组人胰岛素注射液 | human insulin | Injection | Biological Products | Supplementary Application | 2020-05-08 | Lilly France | Lilly France | Certificate Issued | 2021-03-25 | view |
JYSB2000166 | 重组人胰岛素注射液 | human insulin | Injection | Biological Products | Supplementary Application | 2020-05-09 | Lilly France | Lilly France | Certificate Issued | 2021-03-25 | view |
JYSB2000167 | 重组人胰岛素注射液 | human insulin | Injection | Biological Products | Supplementary Application | 2020-05-09 | Lilly France | Lilly France | Certificate Issued | 2021-03-25 | view |
JYSZ2100003 | 重组人胰岛素注射液 | human insulin | Injection | Biological Products | License Renew | 2021-01-28 | 丹麦诺和诺德公司 | Novo Nordisk A/S | In Review | 2021-01-27 | view |
JYSB2100006 | 精蛋白重组人胰岛素注射液(预混30/70) | Isophane Protamine Recombinant Human Insulin | Injection | Biological Products | Supplementary Application | 2021-01-08 | 合肥亿帆生物制药有限公司 | Hefei Yifan Biopharmaceuticals Inc | Filed | 2021-01-22 | view |
JYSB2100005 | 重组人胰岛素注射液 | human insulin | Injection | Biological Products | Supplementary Application | 2021-01-08 | 合肥亿帆生物制药有限公司 | Hefei Yifan Biopharmaceuticals Inc | Filed | 2021-01-22 | view |
JYSB2100010 | 精蛋白重组人胰岛素注射液 | Isophane Protamine Recombinant Human Insulin | Injection | Biological Products | Supplementary Application | 2021-01-08 | 合肥亿帆生物制药有限公司 | Hefei Yifan Biopharmaceuticals Inc | Filed | 2021-01-22 | view |
JYSB2100004 | 重组人胰岛素注射液 | human insulin | Injection | Biological Products | Supplementary Application | 2021-01-08 | 合肥亿帆生物制药有限公司 | Hefei Yifan Biopharmaceuticals Inc | Filed | 2021-01-22 | view |
JYSB2100009 | 精蛋白重组人胰岛素注射液 | Isophane Protamine Recombinant Human Insulin | Injection | Biological Products | Supplementary Application | 2021-01-08 | 合肥亿帆生物制药有限公司 | Hefei Yifan Biopharmaceuticals Inc | Filed | 2021-01-22 | view |
JYSB2100008 | 精蛋白重组人胰岛素注射液(预混30/70) | Isophane Protamine Recombinant Human Insulin | Injection | Biological Products | Supplementary Application | 2021-01-08 | 合肥亿帆生物制药有限公司 | Hefei Yifan Biopharmaceuticals Inc | Filed | 2021-01-22 | view |
JYSB2100007 | 精蛋白重组人胰岛素注射液(预混30/70) | Isophane Protamine Recombinant Human Insulin | Injection | Biological Products | Supplementary Application | 2021-01-08 | 合肥亿帆生物制药有限公司 | Hefei Yifan Biopharmaceuticals Inc | Filed | 2021-01-22 | view |
JYSB2000663 | 精蛋白人胰岛素注射液 | Isophane Protamine Human Insulin | Injection | Biological Products(3.1) | Supplementary Application | 2020-12-28 | 丹麦诺和诺德公司 | Novo Nordisk A/S | Filed | 2021-01-11 | view |
JYSB2000666 | 精蛋白人胰岛素注射液 | Isophane Protamine Human Insulin | Injection | Biological Products(3.1) | Supplementary Application | 2020-12-28 | 丹麦诺和诺德公司 | Novo Nordisk A/S | Filed | 2021-01-11 | view |
JYSB2000665 | 精蛋白人胰岛素注射液 | Isophane Protamine Human Insulin | Injection | Biological Products(3.1) | Supplementary Application | 2020-12-28 | 丹麦诺和诺德公司 | Novo Nordisk A/S | Filed | 2021-01-11 | view |